DOCSLIB.ORG

Intentionally Added Microplastics IUPAC N

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Intentionally Added Microplastics IUPAC N ANNEX to the ANNEX XV RESTRICTION REPORT PROPOSAL FOR A RESTRICTION SUBSTANCE NAME(S): intentionally added microplastics IUPAC NAME(S): N/A EC NUMBER(S): N/A CAS NUMBER(S): N/A CONTACT DETAILS OF THE DOSSIER SUBMITTER: European Chemicals Agency Annankatu 18, PO BOX 400, FI-00121, Helsinki, Finland VERSION NUMBER: 1.2 DATE: 22 August 2019 Annankatu 18, P.O. Box 400, FI-00121 Helsinki, Finland | Tel. +358 9 686180 | Fax +358 9 68618210 | echa.europa.eu ANNEX TO THE ANNEX XV RESTRICTION REPORT – MICROPLASTICS Contents Annex A : Background ............................................................................................ 1 A.1. Examples of definitions for ‘microplastics’ ....................................................................... 1 A.2. Other legislations on intentionally added microplastics .................................................... 10 A.2.1. EU Member State legislation on intentionally added microplastics .............................. 10 A.2.2. Legislation on intentionally added microplastics outside of the European Union ............ 12 A.2.3. Manufacture ...................................................................................................... 14 Annex B. Derivation of a regulatory definition of microplastic .............................. 15 B.1. Substance ................................................................................................................ 15 B.1.1. Presence of a particle or ‘polymer-containing particle’ .............................................. 15 B.1.2. (Bio)degradation of microplastics .......................................................................... 24 Annex C. Hazard, releases, exposure and risk ...................................................... 39 C.1. Summary of review articles ........................................................................................ 39 C.2. Most influential studies ............................................................................................... 74 Annex D. Impacts Assessment ........................................................................... 105 D.1. Analysis of risk management options (RMOs) ............................................................... 105 D.2. Other evaluated restriction options ............................................................................. 105 D.3. Other Union-wide risk management options than restriction ........................................... 108 D.4. Agricultural and Horticultural Products .........................................................................112 D.4.1. Current use ......................................................................................................113 D.4.2. Alternatives ......................................................................................................123 D.4.3. Restriction scenarios ..........................................................................................126 D.4.4. Environmental and health impacts ....................................................................... 129 D.4.5. Economic impacts .............................................................................................131 D.4.6. Other impacts ...................................................................................................135 D.4.7. Proportionality to risk ........................................................................................137 D.4.8. Uncertainties and sensitivities .............................................................................138 D.4.9. Summary .........................................................................................................139 D.5. Cosmetic Products ....................................................................................................139 D.5.1. Use and functions .............................................................................................140 D.5.2. Baseline ...........................................................................................................146 D.5.3. Rinse-off cosmetic products containing microbeads with exfoliating or cleansing functions ...................................................................................................................148 D.5.4. Other rinse-off cosmetic products ........................................................................152 i ANNEX TO THE ANNEX XV RESTRICTION REPORT – MICROPLASTICS D.5.5. Leave-on cosmetic products ...............................................................................166 D.6. Detergents and maintenance products ........................................................................182 D.6.1. Other Union-wide risk management measures than restriction ................................. 182 D.6.2. Use .................................................................................................................183 D.6.3. Uses, functions and alternatives ..........................................................................190 D.6.4. Overview of restriction response and restriction scenarios ....................................... 196 D.6.5. Restriction scenarios and key assumptions ............................................................197 D.6.6. Other impacts ...................................................................................................206 D.6.7. Cost-effectiveness, affordability and proportionality to risk ...................................... 207 D.6.8. Uncertainties and sensitivity analysis ...................................................................209 D.6.9. Impact of scope variations on proportionality to risk ............................................... 209 D.7. Medical devices (MD) and in vitro diagnostic medical devices (IVD MD) ............................ 209 D.7.1. Uses and functions ............................................................................................209 D.7.2. Baseline – tonnage used and releases ..................................................................212 D.7.3. Alternatives ......................................................................................................213 D.7.4. Other existing regulatory provisions .....................................................................214 D.7.5. Proposed action ................................................................................................215 D.7.6. Impact of scope variations on the proportionality to risk ......................................... 216 D.7.7. Uncertainties ....................................................................................................217 D.8. Medicinal products for human and veterinary use .......................................................... 217 D.8.1. Uses and functions: microplastics as pharmaceutical excipient or active substance ..... 217 D.8.2. Baseline – tonnage used and releases ..................................................................224 D.8.3. Alternatives ......................................................................................................228 D.8.4. Other existing regulatory provisions .....................................................................229 D.8.5. Proposed action ................................................................................................231 D.8.6. Impact of scope variations on the proportionality to risk ......................................... 233 D.8.7. Uncertainties ....................................................................................................233 D.9. Food supplements and medical food ............................................................................234 D.10. Oil & gas ............................................................................................................... 234 D.10.1. Uses ..............................................................................................................234 D.10.2. Alternatives ....................................................................................................239 D.10.3. Proposed action ..............................................................................................241 D.10.4. Existing provisions ...........................................................................................242 D.10.5. Analysis of a potential restriction on use under REACH .......................................... 248 D.10.6. Conclusion on proposed action for microplastic use in oil & gas .............................. 250 D.11. Paints and coatings .................................................................................................251 D.11.1. Use of microplastics in paints and coatings .......................................................... 252 D.11.2. Baseline – tonnages used & emitted ...................................................................259 ii ANNEX TO THE ANNEX XV RESTRICTION REPORT – MICROPLASTICS D.11.3. Alternatives ....................................................................................................263 D.11.4. Proposed action ..............................................................................................264 D.12. Option value theory ................................................................................................266 D.12.1. Introduction ...................................................................................................266 D.12.2. Model ............................................................................................................266
Load more

Recommended publications
  • (PHBV) Co-Polymer: a Critical Review
    Rev Environ Sci Biotechnol (2021) 20:479–513 https://doi.org/10.1007/s11157-021-09575-z (0123456789().,-volV)(0123456789().,-volV) REVIEW PAPER Improving biological production of poly(3-hydroxybutyrate- co-3-hydroxyvalerate) (PHBV) co-polymer: a critical review Grazia Policastro . Antonio Panico . Massimiliano Fabbricino Received: 23 January 2021 / Accepted: 2 April 2021 / Published online: 13 April 2021 Ó The Author(s) 2021 Abstract Although poly(3-hydroxybutyrate-co-3- indicates that the addition of 3HV precursors is hydroxyvalerate) (PHBV) is the most promising capable to dramatically enhance the hydroxyvalerate biopolymer for petroleum-based plastics replacement, fraction in the produced biopolymers. On the other the low processes productivity as well as the high sale hand, due to the high costs of the 3HV precursors, the price represent a major barrier for its widespread utilization of wild bacterial species capable to produce usage. The present work examines comparatively the the hydroxyvalerate fraction from unrelated carbon existing methods to enhance the yield of the PHBV co- sources (i.e. no 3HV precursors) also can be consid- polymer biologically produced and/or reduce their ered a valuable strategy for costs reduction. Moreover, costs. The study is addressed to researchers working metabolic engineering techniques can be successfully on the development of new biological production used to promote 3HV precursors-independent biosyn- methods and/or the improvement of those currently thesis pathways and enhance the process productivity. used. At this aim, the authors have considered the The use of mixed cultures or extremophile bacteria analysis of some crucial aspects related to substrates avoids the need of sterile working conditions, and and microorganism’s choice.
    [Show full text]
  • Rastislav Kulich Resume Dec 2010
    RASTO KULICH, V Tunich 3, 120 00 Prague, Czech Republic, [email protected]; cell: +420 724 684 127 experience 2006- MCKINSEY & COMPANY PRAGUE, CZECH REPUBLIC (CR) present Senior engagement manager (Associate till Nov ‘08) Consistent top 20% performance rating Primary focus on strategic due diligences in consumer goods for private equity and strategic investors - 11 projects • Pet-food target in Netherlands, Germany and CEE, spirits in Turkey, food target in Ireland, FMCG target in Tanzania and Kenya, certification/testing target in France, frozen-food distribution in Poland and Czech, beverage target in Germany and Russia, online portal in Czech, due diligence guide for beverage client in UK, Internal Due Diligence Guide in Consumer Goods for McKinsey Europe Secondary focus sales & marketing – 10 projects including major pricing, commercial-excellence, lean and route-to- market projects in consumer-goods in Switzerland, South Africa, Czech, Poland, Russia • Created value estimated at $20 million via new route-to-market strategy for leading beverage client in Poland • Co-delivered profit increase of $25 million on European-wide pricing project for leading beverage client • Increased sales force productivity by 40% via commercial excellence project for pharmaceutical client in CR • Reduced number of calls in call center by 35% via addressing root cause in a lean project for energy company in CR 2006 - 2007 ERGONI.COM BOSTON, USA/MUMBAI, INDIA Co-founder • Co-founded internet startup built on mass-customization concept for luxury shirts
    [Show full text]
  • An Assessment Report on Microplastics
    An Assessment Report on Microplastics This document was prepared by B Stevens, North Carolina Coastal Federation Table of Contents What are Microplastics? 2 Where Do Microplastics Come From? 3 Primary Sources 3 Secondary Sources 5 What are the Consequences of Microplastics? 7 Marine Ecosystem Health 7 Water Quality 8 Human Health 8 What Policies/Practices are in Place to Regulate Microplastics? 10 Regional Level 10 Outer Banks, North Carolina 10 Other United States Regions 12 State Level 13 Country Level 14 United States 14 Other Countries 15 International Level 16 Conventions 16 Suggested World Ban 17 International Campaigns 18 What Solutions Already Exist? 22 Washing Machine Additives 22 Faucet Filters 23 Advanced Wastewater Treatment 24 Plastic Alternatives 26 What Should Be Done? 27 Policy Recommendations for North Carolina 27 Campaign Strategy for the North Carolina Coastal Federation 27 References 29 1 What are Microplastics? The category of ‘plastics’ is an umbrella term used to describe synthetic polymers made from either fossil fuels (petroleum) or biomass (cellulose) that come in a variety of compositions and with varying characteristics. These polymers are then mixed with different chemical compounds known as additives to achieve desired properties for the plastic’s intended use (OceanCare, 2015). Plastics as litter in the oceans was first reported in the early 1970s and thus has been accumulating for at least four decades, although when first reported the subject drew little attention and scientific studies focused on entanglements, ‘ghost fishing’, and ingestion (Andrady, 2011). Today, about 60-90% of all marine litter is plastic-based (McCarthy, 2017), with the total amount of plastic waste in the oceans expected to increase as plastic consumption also increases and there remains a lack of adequate reduce, reuse, recycle, and waste management tactics across the globe (GreenFacts, 2013).
    [Show full text]
  • Compositions Comprising Drospirenone Molecularly
    (19) & (11) EP 1 748 756 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: A61K 9/00 (2006.01) A61K 9/107 (2006.01) 29.04.2009 Bulletin 2009/18 A61K 9/48 (2006.01) A61K 9/16 (2006.01) A61K 9/20 (2006.01) A61K 9/14 (2006.01) (2006.01) (2006.01) (21) Application number: 05708751.2 A61K 9/70 A61K 31/565 (22) Date of filing: 10.03.2005 (86) International application number: PCT/IB2005/000665 (87) International publication number: WO 2005/087194 (22.09.2005 Gazette 2005/38) (54) COMPOSITIONS COMPRISING DROSPIRENONE MOLECULARLY DISPERSED ZUSAMMENSETZUNGEN AUS DROSPIRENON IN MOLEKULARER DISPERSION DES COMPOSITIONS CONTENANT DROSPIRENONE A DISPERSION MOLECULAIRE (84) Designated Contracting States: (72) Inventors: AT BE BG CH CY CZ DE DK EE ES FI FR GB GR • FUNKE, Adrian HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR D-14055 Berlin (DE) Designated Extension States: • WAGNER, Torsten AL BA HR MK YU 13127 Berlin (DE) (30) Priority: 10.03.2004 EP 04075713 (74) Representative: Wagner, Kim 10.03.2004 US 551355 P Plougmann & Vingtoft a/s Sundkrogsgade 9 (43) Date of publication of application: P.O. Box 831 07.02.2007 Bulletin 2007/06 2100 Copenhagen Ø (DK) (60) Divisional application: (56) References cited: 08011577.7 / 1 980 242 EP-A- 1 260 225 EP-A- 1 380 301 WO-A-01/52857 WO-A-20/04022065 (73) Proprietor: Bayer Schering Pharma WO-A-20/04041289 US-A- 5 569 652 Aktiengesellschaft US-A- 5 656 622 US-A- 5 789 442 13353 Berlin (DE) Note: Within nine months of the publication of the mention of the grant of the European patent in the European Patent Bulletin, any person may give notice to the European Patent Office of opposition to that patent, in accordance with the Implementing Regulations.
    [Show full text]
  • (WHO) Report on Microplastics in Drinking Water
    Microplastics in drinking-water Microplastics in drinking-water ISBN 978-92-4-151619-8 © World Health Organization 2019 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Suggested citation. Microplastics in drinking-water. Geneva: World Health Organization; 2019. Licence: CC BY-NC-SA 3.0 IGO. Cataloguing-in-Publication (CIP) data. CIP data are available at http://apps.who.int/iris. Sales, rights and licensing. To purchase WHO publications, see http://apps.who.int/bookorders. To submit requests for commercial use and queries on rights and licensing, see http://www.who.int/about/licensing.
    [Show full text]
  • HIGH-PERFORMANCE BLENDER EXPLORIAN SERIES VM0201 S Y M B O L S
    E310 HIGH-PERFORMANCE BLENDER EXPLORIAN SERIES VM0201 S YMBOL S Warning and Caution NEVER touch moving parts. Keep hands and utensils out of the container. Electric Shock Hazard High temperature when blending hot liquids Unplug while not in use, before cleaning, changing accessories or touching parts that move while the blender is in use Operate with the lid and lid plug in place Read and understand owner’s manual DO NOT immerse Parts will become hot with extended use. DO NOT touch the drive socket in the blender base or the drive spline in the blade base DO NOT use your 20 ounce (0.6 L) cup to heat ingredients or to blend hot liquids DO NOT use the cups (including the blade base or lids) in the microwave I O On/Off ©2018 Vita-Mix Corporation. No part of this publication may be reproduced or transmitted in any form or by any means, or pulse stored in a database or retrieval system, without the written permission of Vita-Mix Corporation. S PECIFICATION S Voltage: 220-240 V Height (with 48 oz. container on base): 18 inches Begin Your Adventure Frequency: 50-60 Hz Width: 8 inches vitamix.com Watts: 1000-1200 W Depth: 11 inches I M P O R TA N T I N STRUCTION S FOR S AFE U S E WARNING: to avoid the risk of serious injury when using your Vitamix® blender, basic safety precau- tions should be followed, including the following. READ ALL INSTRUCTIONS, SAFEGUARDS AND WARNINGS BEFORE OPERATING BLENDER. 1. Read all instructions.
    [Show full text]
  • 4 S2 2 Box&Cummins-Policy Talk
    Data Supported Solutions for Microplastics Pollution in San Francisco Bay Carolynn Box and Anna Cummins 5 Gyres Research supports the plastic pollution movement Research often backbone to action campaigns Local data can support local policy action Example: microbead ban in California This project was designed to develop scientifically supported solutions Policy Expert Committee • 22 experts / stakeholders • Diverse group of views Policy Recommendation Report • Based on project results 1 Support policies that reduce single-use plastics and packaging Local: San Francisco and others are looking to Berkeley’s disposable free ordinance Statewide: Comprehensive legislation that reduces single-use plastics 1 Support policies that reduce single-use plastics and packaging Project results • Surface water had polyethylene and polypropylene fragments, polystyrene foam • Computer modeling shows that buoyant particles are transported out of Bay Explore green stormwater 2 infrastructure as a tool to reduce microplastics Green stormwater infrastructure • Remove hard surfaces to reduce runoff to nearby water bodies Related study by SFEI • 90% removal of microplastics • Maintenance is ongoing Explore green stormwater 2 infrastructure as a tool to reduce microplastics Project results • 7 trillion microplastics enter through stormwater, 300 times more than wastewater • Half of the particles were rubbery black fragments, likely linked to tires More research on stormwater is needed 3 Identify and prioritize intervention points for fibers by filtration Evaluate
    [Show full text]
  • MICROPLASTICS PROJECT Science-Supported Solutions and Policy Recommendations
    SAN FRANCISCO BAY MICROPLASTICS PROJECT Science-Supported Solutions and Policy Recommendations Authors: Carolynn Box (5 Gyres) Anna Cummins (5 Gyres) September 2019 CONTENTS EXECUTIVE SUMMARY 2 1. AN INTRODUCTION TO THE PLASTIC POLLUTION MOVEMENT 4 What are microplastics, microparticles, and microfibers? 6 Why are microplastics a potential threat? 8 What are the pathways and sources of microplastics? 10 2. USING SCIENCE TO GUIDE ACTION 13 Development of this report 14 Use of this report 14 3. SAN FRANCISCO BAY MICROPLASTICS PROJECT FINDINGS 15 Rainy weather washes microplastics into Bay waters 15 Sediment in the lower south Bay had more microplastics 16 Prey fish consume fibers 18 High levels of rubbery fragments and other microplastics and microfibers found in stormwater 18 Wastewater samples dominated by microfibers 19 Quality control samples reveal microfibers are everywhere 20 Related Bay Area microplastics research 20 4. RECOMMENDATIONS FOR SAN FRANCISCO BAY 21 Recommendation #1: Support legislation that reduces single-use plastics and plastic packaging in the Bay Area and statewide 22 Recommendation #2: Explore green stormwater infrastructure management options to reduce microplastics from entering San Francisco Bay 24 Recommendation #3: Identify and prioritize intervention points for microfibers around filtration 26 Recommendation #4: Support the development of a San Francisco Bay Microplastics Management Strategy to reduce microplastics 28 Recommendation #5: Encourage textile industry to standardize methods to understand microfiber
    [Show full text]
  • Holiday Turkey
    Holiday Turkey You can buy different types of turkeys to cook. Read the label on the turkey carefully. Fresh Turkey Frozen Stuffed Frozen Turkey without Stuffing Look for a best-before date on the Turkey Take the turkey out of the freezer package. You must cook the turkey You can also buy a and thaw in the refrigerator. before this date. frozen turkey that Leave the turkey in its original wrapping. What if there is no date on the has stuffing inside. Put it in a large pan. Put it in the coldest package? You can keep the turkey You do not thaw part of the refrigerator. in the refrigerator for 1 - 2 days this turkey - cook it It will take about 10 hours per kilogram before you cook it. from frozen! Follow (about 5 hours per pound) to thaw. For It takes longer to cook a fresh the directions on example, it could take 2 days for a small turkey. Add 5 minutes per kilogram the label. turkey and 4 days for a large turkey. (3 minutes per pound) to the times You must cook a thawed turkey in the cooking chart. within 24 hours. 1 Prepare the turkey 2 Cook turkey at 425°F for Preheat the oven to 425°F. the first 30 minutes Take the plastic off the turkey. Then turn the oven down to 325°F. Continue roasting for: Take out the neck and bag of giblets. Don’t leave them inside the turkey. 4.5 kg (10 lb) 2 1/4 – 2 1/2 hours You can cook the neck alongside the turkey or you 7 kg (15 lb) 2 1/2 – 3 hours can use the neck, heart and gizzard to make stock 9 kg (20 lb) 3 1/2 – 4 hours or gravy.
    [Show full text]
  • Venturist™ Series S Y M B O L S
    Venturist™ Series S YMBOL S V1200I AND V1500I HIGH-PERFORMANCE BLENDERS Warning and Caution VM0195E NEVER touch moving parts. Keep hands and utensils out of Your Adventure Awaits the container Electric Shock Hazard High temperature when blending hot liquids Unplug while not in use, before cleaning, changing accessories or touching parts that move while the blender is in use Operate with the lid and lid plug in place Read and understand owner’s manual DO NOT immerse Parts will become hot with extended use. DO NOT touch the drive socket in the blender base or the drive spline in the blade base DO NOT use your 20 oz. (0.6 L) cup or 8 oz. (240 ml) bowl to heat ingredients or to blend hot liquids. Standby (Model V1500i) I/O On/Off I Start/Stop Pulse S PECIFICATION S Model V1500i Program Symbols (correspond to Vitamix Recipes) - Voltage: 220/240 V Height (with 64 oz. (2 L) container on blender Note: V1200i does not include programs base): 17 inches Smoothies Frequency: 50 - 60 Hz Width: 8 inches Watts 1200-1400 W Depth: 11 inches Frozen Desserts • This device complies with part 15 of the FCC Rules. Operation is subject to the following two conditions: (1) This device may not cause harmful interference, and (2) this device must accept any interference received, including interference that Soups may cause undesired operation. • This device complies with Industry Canada licence-exempt RSS standard(s). Operation is subject to the following two conditions: (1) this device may not Self-Cleaning cause interference, and (2) this device must accept any interference, including interference that may cause undesired operation of the device.
    [Show full text]
  • The Future of the Skincare Market in the UAE to 2017
    673 1. The Future of the Skincare Market in the UAE to 2017 Market Size, Distribution and Brand Share, Key Events and Competitive Landscape Reference Code: HB0158ER Published: March 2014 www.canadean-winesandspirits.com The Future of the Skincare Market in the UAE to 2017 Published: March 2014 Table of Contents 1. Introduction ............................................................................................... 16 1.1 What is this Report About?................................................................................. 16 1.2 Definitions .......................................................................................................... 16 1.2.1 This report provides 2012 actual sales; while forecasts are provided for 2013 – 2017 .... 16 1.2.2 Category Definitions .......................................................................................................... 16 1.2.3 Distribution Channel Definitions ........................................................................................ 18 1.2.4 Volume Units and Aggregations ........................................................................................ 19 1.2.5 CAGR Definition and Calculation ...................................................................................... 19 1.2.6 Graphical representation of Brands ................................................................................... 20 1.2.7 Exchange Rates ................................................................................................................ 20 1.2.8
    [Show full text]
  • Hydroxyisohexyl 3-Cyclohexene Carboxaldehyde
    SCCP/1456/11 Revision of 27 July 2012 Scientific Committee on Consumer Safety SCCS OPINION ON HYDROXYISOHEXYL 3-CYCLOHEXENE CARBOXALDEHYDE (HICC) The SCCP adopted this opinion at its 13th plenary of 13-14 December 2011 SCCS/1456/11 Opinion on Hydroxyisohexyl 3-cyclohexene carboxaldehyde ___________________________________________________________________________________________ About the Scientific Committees Three independent non-food Scientific Committees provide the Commission with the scientific advice it needs when preparing policy and proposals relating to consumer safety, public health and the environment. The Committees also draw the Commission's attention to the new or emerging problems which may pose an actual or potential threat. They are: the Scientific Committee on Consumer Safety (SCCS), the Scientific Committee on Health and Environmental Risks (SCHER) and the Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) and are made up of external experts. In addition, the Commission relies upon the work of the European Food Safety Authority (EFSA), the European Medicines Agency (EMA), the European Centre for Disease prevention and Control (ECDC) and the European Chemicals Agency (ECHA). SCCS The Committee shall provide opinions on questions concerning all types of health and safety risks (notably chemical, biological, mechanical and other physical risks) of non-food consumer products (for example: cosmetic products and their ingredients, toys, textiles, clothing, personal care and household products such as detergents, etc.) and services (for example: tattooing, artificial sun tanning, etc.). Scientific Committee members Jürgen Angerer, Ulrike Bernauer, Claire Chambers, Qasim Chaudhry, Gisela Degen, Elsa Nielsen, Thomas Platzek, Suresh Chandra Rastogi, Vera Rogiers, Christophe Rousselle, Tore Sanner, Jan van Benthem, Jacqueline van Engelen, Maria Pilar Vinardell, Rosemary Waring, Ian R.
    [Show full text]